2Seventy Bio Inc Working Capital to Net Assets Ratio
2Seventy Bio Inc working capital to net assets ratio. 2Seventy Bio Inc (TSVT) has a Working Capital to Net Assets ratio of 73.5% as of March 2025. Working capital of $157.19 Million (current assets of $198.58 Million minus current liabilities of $41.40 Million) is measured against net assets of $213.96 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 2Seventy Bio Inc (TSVT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of 2Seventy Bio Inc (2019–2024)
Working capital to net assets ratio of 2Seventy Bio Inc from 2019 to 2024. This chart shows how 2Seventy Bio Inc's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of March 2025, the ratio stands at 73.5%, reflecting working capital of $157.19 Million against net assets of $213.96 Million USD. See TSVT cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
2Seventy Bio Inc Working Capital to Net Assets Ratio by Year (2019–2024)
2Seventy Bio Inc working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for 2Seventy Bio Inc from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is 2Seventy Bio Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 69.8% | $147.16 Million | $210.81 Million | $187.26 Million | $40.09 Million | ▲ +0.1 pp |
| 2023 | 69.7% | $177.99 Million | $255.30 Million | $237.76 Million | $59.78 Million | ▼ -1.5 pp |
| 2022 | 71.2% | $221.09 Million | $310.47 Million | $300.88 Million | $79.79 Million | ▲ +17.5 pp |
| 2021 | 53.7% | $193.18 Million | $359.82 Million | $291.56 Million | $98.39 Million | ▲ +121.7 pp |
| 2020 | -68.0% | $-50.76 Million | $74.63 Million | $25.10 Million | $75.87 Million | ▲ +120.9 pp |
| 2019 | -188.9% | $-82.56 Million | $43.69 Million | $20.84 Million | $103.40 Million | — |